BR9510664A - Localização não invasiva de um conjugado de emissão de luz em um animal - Google Patents

Localização não invasiva de um conjugado de emissão de luz em um animal

Info

Publication number
BR9510664A
BR9510664A BR9510664-2A BR9510664A BR9510664A BR 9510664 A BR9510664 A BR 9510664A BR 9510664 A BR9510664 A BR 9510664A BR 9510664 A BR9510664 A BR 9510664A
Authority
BR
Brazil
Prior art keywords
animal
light emission
conjugate
disclosed
methods
Prior art date
Application number
BR9510664-2A
Other languages
English (en)
Inventor
Christopher H Contag
Pamela R Contag
David A Benaron
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27170688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9510664(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Priority to BR9510664-2A priority Critical patent/BR9510664A/pt
Publication of BR9510664A publication Critical patent/BR9510664A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
    • A61K49/0084—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion liposome, i.e. bilayered vesicular structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine

Abstract

"LOCALIZAçãO NãO INVASIVA DE CONJUGADO EMISSOR DE LUZ EM UM MAMìFERO" A presente invenção refere-se a métodos e composições para detectar e localizar luz que se origina de um mamífero. Também mostrados estão métodos para mirar a emissão de luz a regiões selecionada, bem como para rastrear entidades dentro do mamífero. Além disso, são mostrados modelos de animais para estados de doença, bem como métodos para localizar e rastrear a progressão da doença ou um agente patogênico dentro do animal, e para selecionar compostos terapêuticos putativos eficazes para inibir a doença ou o agente patogênico.
BR9510664-2A 1994-07-01 1995-11-17 Localização não invasiva de um conjugado de emissão de luz em um animal BR9510664A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR9510664-2A BR9510664A (pt) 1994-07-01 1995-11-17 Localização não invasiva de um conjugado de emissão de luz em um animal

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/270,631 US5650135A (en) 1994-07-01 1994-07-01 Non-invasive localization of a light-emitting conjugate in a mammal
CA002237983A CA2237983C (en) 1994-07-01 1995-11-17 Non-invasive localization of a light-emitting conjugate in a mammal
PCT/US1995/015040 WO1997018841A1 (en) 1994-07-01 1995-11-17 Non-invasive localization of a light-emitting conjugate in a mammal
BR9510664-2A BR9510664A (pt) 1994-07-01 1995-11-17 Localização não invasiva de um conjugado de emissão de luz em um animal

Publications (1)

Publication Number Publication Date
BR9510664A true BR9510664A (pt) 2001-07-17

Family

ID=27170688

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9510664-2A BR9510664A (pt) 1994-07-01 1995-11-17 Localização não invasiva de um conjugado de emissão de luz em um animal

Country Status (13)

Country Link
US (1) US5650135A (pt)
EP (2) EP0861093B1 (pt)
JP (1) JP3786704B2 (pt)
AT (1) ATE193453T1 (pt)
AU (1) AU4285096A (pt)
BR (1) BR9510664A (pt)
CA (1) CA2237983C (pt)
DE (2) DE1016419T1 (pt)
DK (1) DK0861093T3 (pt)
ES (2) ES2147621T3 (pt)
GR (1) GR3034110T3 (pt)
HK (1) HK1018747A1 (pt)
WO (1) WO1997018841A1 (pt)

Families Citing this family (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650135A (en) * 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US7255851B2 (en) * 1994-07-01 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US6217847B1 (en) 1994-07-01 2001-04-17 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US6540981B2 (en) * 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
EP1820517A3 (en) * 1995-11-17 2009-10-21 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US6247995B1 (en) 1996-02-06 2001-06-19 Bruce Bryan Bioluminescent novelty items
US8349602B1 (en) 1996-04-19 2013-01-08 Xenogen Corporation Biodetectors targeted to specific ligands
US6416960B1 (en) 1996-08-08 2002-07-09 Prolume, Ltd. Detection and visualization of neoplastic tissues and other tissues
ATE290205T1 (de) 1996-12-12 2005-03-15 Prolume Ltd Vorrichtung und verfahren zum nachweis und identifizieren von infektiösen wirkstoffen
US6232523B1 (en) 1997-04-28 2001-05-15 Anticancer, Inc. Metastasis models using green fluorescent protein (GFP) as a marker
US6251384B1 (en) 1997-04-28 2001-06-26 Anticancer, Inc. Metastasis models using green fluorescent protein (GFP) as a marker
AU749338B2 (en) 1997-04-28 2002-06-27 Anticancer, Inc. Metastasis models using green fluorescent protein (GFP) as a marker
WO1998048846A1 (en) * 1997-04-29 1998-11-05 Nycomed Imaging As Light imaging contrast agents
US6656734B1 (en) 1997-07-01 2003-12-02 Transgene S.A. Compositions for the delivery of polynucleotides to cells
US6638501B1 (en) 1997-09-29 2003-10-28 Neurospheres Holdings Ltd. Use of multipotent neural stem cell progeny to augment non-neural tissues
US7294755B1 (en) 1997-11-14 2007-11-13 Cedars-Sinai Medical Center Genetic modification of male germ cells for generation of transgenic species and genetic therapies
JP2001523468A (ja) * 1997-11-14 2001-11-27 セダーシナイ メディカル センター トランスジェニック種の産生のための雄性生殖細胞のトランスフェクションおよび移入
US6734338B1 (en) 1997-11-14 2004-05-11 Cedars-Sinai Medical Center Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies
US6846625B1 (en) * 1998-01-09 2005-01-25 Cubist Pharmaceuticals, Inc. Method for identifying validated target and assay combination for drug development
WO1999037142A1 (en) * 1998-01-27 1999-07-29 Novo Nordisk A/S Method for producing transgenic animals
WO1999045354A2 (en) * 1998-03-02 1999-09-10 Biosensing Technologies Ltd. Luminescent microbe assay
US6174291B1 (en) 1998-03-09 2001-01-16 Spectrascience, Inc. Optical biopsy system and methods for tissue diagnosis
EP1091685B1 (en) * 1998-04-07 2008-06-11 Cytyc Corporation Devices for the localization of lesions in solid tissue
US6592847B1 (en) * 1998-05-14 2003-07-15 The General Hospital Corporation Intramolecularly-quenched near infrared flourescent probes
US6226352B1 (en) * 1998-09-08 2001-05-01 Veritas Pharmaceuticals, Inc. System and method for radiographic imaging of tissue
US20010038682A1 (en) * 1998-09-08 2001-11-08 Jesse Salb Radiographic assessment of tissue response to compounds
US6751290B2 (en) 1998-09-08 2004-06-15 Veritas Pharmaceuticals, Inc. Radiographic assessment of tissue after exposure to a compound
US6723746B2 (en) 1998-09-08 2004-04-20 Veritas Pharmaceuticals, Inc. Functional radiographic imaging methods and agents
US6299860B1 (en) 1998-10-15 2001-10-09 Fluoro Probe, Inc. Method for viewing diseased tissue located within a body cavity
US6652836B2 (en) 1998-10-15 2003-11-25 Fluoroprobe, Inc. Method for viewing tumor tissue located within a body cavity
US6284223B1 (en) * 1998-10-15 2001-09-04 Fluoroprobe, Inc. Method for viewing tumor tissue located within a body cavity
AU774183B2 (en) * 1998-12-17 2004-06-17 Xenogen Corporation Non-invasive evaluation of physiological response in a mammal
US6610503B1 (en) * 1999-03-17 2003-08-26 Xenogen Corporation Animal models for predicting sepsis mortality
US6495355B1 (en) 1999-06-22 2002-12-17 The Board Of Trustees Of The Leland Stanford Junior University Red-shifted luciferase
US6737245B1 (en) 1999-09-08 2004-05-18 Xenogen Corporation Luciferase expression cassettes and methods of use
JP2003527833A (ja) 1999-10-14 2003-09-24 クロンテック・ラボラトリーズ・インコーポレーテッド 花虫類に由来する発色団／蛍光体、およびそれらの使用法
US6614452B1 (en) * 1999-11-15 2003-09-02 Xenogen Corporation Graphical user interface for in-vivo imaging
US7581191B2 (en) * 1999-11-15 2009-08-25 Xenogen Corporation Graphical user interface for 3-D in-vivo imaging
US6867348B1 (en) 1999-12-16 2005-03-15 Xenogen Corporation Methods and compositions for screening for angiogenesis modulating compounds
IT1311335B1 (it) 1999-12-21 2002-03-12 Otc Optical Technologies Ct S Procedimento e dispositivo per realizzare reticoli in fibra ottica.
AU2001230471A1 (en) * 2000-01-31 2001-08-14 Hadasit Medical Research Services And Development Ltd. Tracking gene expression and metabolic processes in subjects
US6775567B2 (en) * 2000-02-25 2004-08-10 Xenogen Corporation Imaging apparatus
WO2001071009A2 (en) * 2000-03-17 2001-09-27 Anticancer, Inc. Whole-body optical imaging of gene expression and uses thereof
US6748259B1 (en) * 2000-06-15 2004-06-08 Spectros Corporation Optical imaging of induced signals in vivo under ambient light conditions
US7056728B2 (en) * 2000-07-06 2006-06-06 Xenogen Corporation Compositions and methods for use thereof in modifying the genomes of microorganisms
WO2002008431A1 (en) * 2000-07-06 2002-01-31 Xenogen Corporation Compositions and methods for use thereof in modifying the genomes of microorganisms
US6615063B1 (en) 2000-11-27 2003-09-02 The General Hospital Corporation Fluorescence-mediated molecular tomography
US7383076B2 (en) * 2000-11-27 2008-06-03 The General Hospital Corporation Fluorescence-mediated molecular tomography
US20020073441A1 (en) 2000-12-13 2002-06-13 Ross Brian D. Compositions and methods for detecting proteolytic activity
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
US20030044353A1 (en) * 2001-01-05 2003-03-06 Ralph Weissleder Activatable imaging probes
WO2002059562A2 (en) * 2001-01-26 2002-08-01 Colorado State University Research Foundation Analysis of gene expression and biological function using optical imaging
EP1373481A4 (en) * 2001-03-07 2005-04-13 Xenogen Corp PROCESS FOR SCREENING ON THE INTRODUCTION OF DNA TO A TARGET CELL
DE02708018T1 (de) * 2001-03-09 2004-09-30 Gene Stream Pty. Ltd. Neue expressionsvektoren
US6855510B2 (en) 2001-03-20 2005-02-15 Dana Farber Cancer Institute, Inc. Pharmaceuticals and methods for treating hypoxia and screening methods therefor
US7176345B2 (en) * 2001-03-20 2007-02-13 Dana-Farber Cancer Institute, Inc. Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor
US7919274B2 (en) 2001-03-20 2011-04-05 Dana-Farber Cancer Institute, Inc. Light-emitting fusion proteins and diagnostic and therapeutic methods therefor
AU2006200164B2 (en) * 2001-04-09 2007-03-08 Oncofluor, Inc. Method for viewing tumor tissue located within a body cavity
US6858773B2 (en) * 2001-04-20 2005-02-22 Xenogen Corporation Transgenic mice comprising transcription control elements associated with mouse eosinophil peroxidase expression
ATE336717T1 (de) * 2001-05-17 2006-09-15 Xenogen Corp Verfahren und vorrichtung zur feststellung von zieltiefe, helligkeit und grösse in einer körperregion
US6919919B2 (en) * 2002-02-06 2005-07-19 Xenogen Corporation Light calibration device for use in low level light imaging systems
US7116354B2 (en) * 2001-06-20 2006-10-03 Xenogen Corporation Absolute intensity determination for a light source in low level light imaging systems
JP2005520781A (ja) 2001-07-09 2005-07-14 アンチキャンサー インコーポレーテッド 蛍光タンパク質をマーカーとして用いた感染の画像化
US7113217B2 (en) * 2001-07-13 2006-09-26 Xenogen Corporation Multi-view imaging apparatus
US7298415B2 (en) 2001-07-13 2007-11-20 Xenogen Corporation Structured light imaging apparatus
US20040033555A1 (en) * 2001-07-20 2004-02-19 Shawn Louise Anderson Methods using light emission for determining the effeciveness of plant treatment agents in controlling plant disease organisms
US20030053951A1 (en) * 2001-07-26 2003-03-20 Millennium Pharmaceuticals, Inc. Use of non-invasive imaging technologies to monitor in vivo gene-expression
EP1281767A3 (en) * 2001-07-31 2003-05-28 Aladar A. Szalay Light emitting microorganisms and cells for diagnosis and therapy of tumors
AU2002357322A1 (en) * 2001-12-19 2003-07-09 The University Of Chicago Rapidly maturing fluorescent proteins and methods for using the same
DE10202050A1 (de) * 2002-01-18 2003-07-31 Siemens Ag Optisches Bildgebungsverfahren und Vorrichtung zur optischen Bildgebung
WO2003063777A2 (en) * 2002-01-25 2003-08-07 Albany Medical College Rapid phenotypic cell-based hiv assay
US7629573B2 (en) * 2002-02-06 2009-12-08 Xenogen Corporation Tissue phantom calibration device for low level light imaging systems
US7649185B2 (en) * 2002-02-06 2010-01-19 Xenogen Corporation Fluorescent phantom device
US7503323B2 (en) 2002-02-20 2009-03-17 Xenogen Corporation Multiple output anesthesia system
US6922246B2 (en) * 2002-02-22 2005-07-26 Xenogen Corporation Bottom fluorescence illumination assembly for an imaging apparatus
US7474398B2 (en) * 2002-02-22 2009-01-06 Xenogen Corporation Illumination system for an imaging apparatus with low profile output device
US7474399B2 (en) * 2002-02-22 2009-01-06 Xenogen Corporation Dual illumination system for an imaging apparatus and method
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US20050100963A1 (en) 2002-03-01 2005-05-12 Dyax Corporation KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
ES2398393T3 (es) 2002-03-01 2013-03-15 Dyax Corp. Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico y terapia
US20030228261A1 (en) * 2002-06-05 2003-12-11 Aladar Szalay Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
EP1369491A1 (en) * 2002-06-05 2003-12-10 Aladar A. Szalay Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
US7599731B2 (en) * 2002-07-16 2009-10-06 Xenogen Corporation Fluorescent light tomography
US7616985B2 (en) * 2002-07-16 2009-11-10 Xenogen Corporation Method and apparatus for 3-D imaging of internal light sources
WO2004027378A2 (en) 2002-09-20 2004-04-01 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
AU2003286911A1 (en) * 2002-11-04 2004-06-07 Dana-Farber Cancer Institute, Inc. In vivo imaging of e2f-regulated bioluminescent proteins
ATE509946T1 (de) 2002-11-12 2011-06-15 Zakrytoe Aktsionernoe Obschestvo S Evrogens Fluoreszenzproteine und chromoproteine aus nicht- aequorea-hydrozoa-spezies sowie verfahren zur verwendung davon
ATE474922T1 (de) 2002-12-26 2010-08-15 Zakrytoe Aktsionernoe Obschest Fluoreszenzproteine aus copepoda-spezies und verfahren zur verwendung davon
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
WO2004078778A2 (en) 2003-03-03 2004-09-16 Dyax Corp. PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF
WO2004078984A1 (en) 2003-03-05 2004-09-16 Janssen Pharmaceutica N.V. Animal model for the fast identification of pharmaceutical active compounds in vivo
DE602004018927D1 (de) * 2003-06-18 2009-02-26 Genelux Corp Modifizierte rekombinante vacciniaviren, verwendungen davon
US7190991B2 (en) * 2003-07-01 2007-03-13 Xenogen Corporation Multi-mode internal imaging
US7555334B2 (en) * 2003-10-20 2009-06-30 Xenogen Corporation Small animal light intensity monitor
EP1682878A1 (en) * 2003-10-31 2006-07-26 Art Advanced Research Technologies Inc. A time-domain method and apparatus for determining the depth and concentration of a fluorophore in a turbid medium
US7155274B1 (en) 2003-11-21 2006-12-26 Imaging Diagnostic Systems, Inc. Optical computed tomography scanner for small laboratory animals
AU2004303448A1 (en) 2003-12-23 2005-07-07 Mount Sinai Hospital Methods for detecting markers associated with endometrial disease or phase
EP1732944B1 (en) * 2004-04-07 2012-09-05 The University of Chicago Monomeric red fluorescent proteins
US8044996B2 (en) * 2005-05-11 2011-10-25 Xenogen Corporation Surface construction using combined photographic and structured light information
EP2778234B1 (en) * 2005-05-31 2017-09-27 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
US20070025917A1 (en) * 2005-07-26 2007-02-01 General Electric Company Optical imaging based on locally activated bioluminescence
US8203132B2 (en) * 2005-09-08 2012-06-19 Carestream Health, Inc. Apparatus and method for imaging ionizing radiation
US20100220836A1 (en) 2005-09-08 2010-09-02 Feke Gilbert D Apparatus and method for multi-modal imaging
US8050735B2 (en) * 2005-09-08 2011-11-01 Carestream Health, Inc. Apparatus and method for multi-modal imaging
US20090086908A1 (en) * 2005-09-08 2009-04-02 John William Harder Apparatus and method for multi-modal imaging using nanoparticle multi-modal imaging probes
US20090281383A1 (en) * 2005-09-08 2009-11-12 Rao Papineni Apparatus and method for external fluorescence imaging of internal regions of interest in a small animal using an endoscope for internal illumination
US8660631B2 (en) * 2005-09-08 2014-02-25 Bruker Biospin Corporation Torsional support apparatus and method for craniocaudal rotation of animals
WO2007052102A2 (en) * 2005-11-04 2007-05-10 Evrogen, Jsc Modified green fluorescent proteins and methods for using same
NZ569818A (en) * 2005-12-16 2012-07-27 Catherine M Shachaf Diagnostic system for the detection and diagnosis of skin cancer
DK1994149T3 (da) * 2006-01-25 2011-01-17 Evrogen Ip Nye fluorescerende proteiner og fremgangsmåder til anvendelse deraf
US8563703B2 (en) 2006-01-25 2013-10-22 Evrogen IP Joint Stock Company Fluorescent proteins and methods for using same
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
US10335038B2 (en) 2006-08-24 2019-07-02 Xenogen Corporation Spectral unmixing for in-vivo imaging
US10775308B2 (en) * 2006-08-24 2020-09-15 Xenogen Corporation Apparatus and methods for determining optical tissue properties
WO2008094316A2 (en) * 2006-09-22 2008-08-07 Stowers Institute Of Medical Research Novel branchiostoma derived fluorescent proteins
EP2426142A3 (en) 2006-10-16 2012-06-13 Genelux Corporation Modified vaccinia virus strains for use in a diagnostic and therapeutic method
US20110112196A1 (en) 2007-02-08 2011-05-12 Matvey E Lukashev Nrf2 screening assays and related methods and compositions
JP2008224312A (ja) * 2007-03-09 2008-09-25 Olympus Corp 蛍光観察装置
JP4969273B2 (ja) * 2007-03-09 2012-07-04 オリンパス株式会社 蛍光観察装置
WO2008156655A2 (en) 2007-06-15 2008-12-24 Genelux Corporation Vaccinia virus vectors encoding a sodium-dependent transporter protein for imaging and/or treatment of tumors
US20090060843A1 (en) * 2007-08-31 2009-03-05 Biocrine Ab Non-Invasive In Vivo Imaging and Methods for Treating Type I Diabetes
US20090081715A1 (en) * 2007-09-07 2009-03-26 Cobalt Technologies, Inc., A Delaware Corporation Engineered Light-Emitting Reporter Genes
CA2699912A1 (en) 2007-09-19 2009-03-26 Oncofluor, Inc. Method for imaging and treating organs and tissues
WO2009059305A2 (en) * 2007-11-01 2009-05-07 The University Of Chicago Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
US8791427B2 (en) * 2007-12-26 2014-07-29 Olympus Corporation Biological-specimen observation apparatus
WO2009092062A2 (en) 2008-01-18 2009-07-23 Visen Medical, Inc. Fluorescent imaging agents
CA2618163A1 (en) 2008-02-07 2009-08-07 K. W. Michael Siu Head and neck cancer biomarkers
GB2459756B (en) 2008-04-09 2012-04-04 Cobalt Technologies Inc Enhanced ABE fermentation with high yielding butanol tolerant Clostridium strains
JP2009257967A (ja) * 2008-04-17 2009-11-05 Olympus Corp 蛍光観察装置および蛍光観察方法
WO2010021686A1 (en) * 2008-08-18 2010-02-25 Promega Corporation Luminogenic compounds and methods to detect cytochrome p450 3a enzymes
WO2010062787A1 (en) 2008-11-03 2010-06-03 Washington University Bioluminescence imaging of myeloperoxidase activity in vivo, methods, compositions and apparatuses therefor
EP2436756B1 (en) 2009-05-27 2016-08-17 Industry Foundation Of Chonnam National University Selective infarcted-tissue-targeting bacteria and use thereof
AU2010266035B2 (en) * 2009-06-26 2015-02-12 Talfryn S.A. Integrated system and process for bioproduct production
DE202009009799U1 (de) 2009-07-17 2009-09-10 Berthold Technologies Gmbh & Co. Kg Vorrichtung zur Untersuchung von lebenden Tieren
KR101199570B1 (ko) 2009-09-09 2012-11-13 경북대학교 산학협력단 신규한 테트라아자 거대고리 화합물, 제조방법 및 그 용도
WO2011034590A1 (en) 2009-09-18 2011-03-24 Caliper Life Sciences Compositions and methods for in vivo evaluation of bioluminescence
EP2512227B1 (en) 2009-12-17 2016-11-02 Sanofi Animal model expressing luciferase under control of the myelin basic protein promoter (mbp-luci) and use of the model for bioluminescence in vivo imaging
US9018438B2 (en) 2010-07-29 2015-04-28 Kyoto University Screening method for anticancer drugs
WO2012040108A2 (en) 2010-09-20 2012-03-29 Caliper Life Sciences Multivalent fluorescent probes
US8569254B2 (en) 2010-12-10 2013-10-29 National Yang Ming University Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the same
US9446151B2 (en) 2011-04-13 2016-09-20 Caliper Life Sciences, Inc. In vivo imaging of enzymatic activity
JP6415977B2 (ja) 2011-04-15 2018-10-31 ジェネラックス・コーポレイションＧｅｎｅｌｕｘ Ｃｏｒｐｏｒａｔｉｏｎ 弱毒化ワクシニアウイルスのクローン株およびその使用方法
US9314218B2 (en) 2011-06-20 2016-04-19 Caliper Life Sciences, Inc. Integrated microtomography and optical imaging systems
US9657329B2 (en) 2011-11-07 2017-05-23 The Broad Institute Inc. Propeptide-luciferase fusion proteins and methods of use thereof
JP6049305B2 (ja) * 2012-05-25 2016-12-21 オリンパス株式会社 生体試料由来の被験試料の画像を取得する方法
ES2716577T3 (es) 2012-07-31 2019-06-13 Agex Therapeutics Inc Células HLA-G modificadas y métodos
EP2719703A1 (en) 2012-10-12 2014-04-16 Ecole Polytechnique Fédérale de Lausanne (EPFL) Precursor molecule for the synthesis of D-luciferin
JP2014115151A (ja) * 2012-12-07 2014-06-26 Shimadzu Corp 光イメージング装置
WO2015038968A1 (en) 2013-09-13 2015-03-19 The General Hospital Corporation Activatable fibrin-binding probes
WO2015116867A1 (en) 2014-01-29 2015-08-06 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
CN105994086B (zh) * 2016-07-08 2022-02-11 中国人民解放军军事医学科学院毒物药物研究所 一种可控投影模拟实景的斑马鱼行为测试系统
WO2019168948A1 (en) * 2018-02-27 2019-09-06 The Board Of Trustees Of The Leland Stanford Junior University Engineered immune cells as diagnostic probes of disease
US11691976B2 (en) 2018-08-23 2023-07-04 Promega Corporation Coelenterazine analogues
US20240150363A1 (en) 2022-10-14 2024-05-09 Promega Corporation Coelenterazine analogues
CN115992264A (zh) * 2023-02-21 2023-04-21 华中农业大学 一种鸡黄白肤色分子鉴定引物组及其方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE59966T1 (de) * 1983-09-26 1991-02-15 Ehrenfeld Udo Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr.
GB8422650D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
GB8422653D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
CN85109047A (zh) * 1985-11-13 1987-06-03 科技研究公司 应用生物发光或引入其它外源性遗传标记检测或鉴定测试样品中的微生物
US4745181A (en) * 1986-10-06 1988-05-17 Ciba Corning Diagnostics Corp. Polysubstituted aryl acridinium esters
US4762701A (en) * 1986-10-31 1988-08-09 Smithkline Beckman Corporation In vivo cellular tracking
US4912031A (en) * 1987-10-23 1990-03-27 E. I. Du Pont De Nemours And Company Method for detecting carcinomatous and precarcinomatous colo-rectal disease
GB8916806D0 (en) * 1989-07-22 1989-09-06 Univ Wales Medicine Modified proteins
US5650135A (en) * 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal

Also Published As

Publication number Publication date
DE69517344D1 (de) 2000-07-06
ES2152198T1 (es) 2001-02-01
US5650135A (en) 1997-07-22
WO1997018841A1 (en) 1997-05-29
AU4285096A (en) 1997-06-11
EP0861093B1 (en) 2000-05-31
ATE193453T1 (de) 2000-06-15
DE1016419T1 (de) 2001-01-25
ES2147621T3 (es) 2000-09-16
EP1016419A2 (en) 2000-07-05
GR3034110T3 (en) 2000-11-30
CA2237983C (en) 2007-05-22
JP2000502884A (ja) 2000-03-14
CA2237983A1 (en) 1997-05-29
EP1016419B1 (en) 2013-02-27
DE69517344T2 (de) 2001-01-18
EP1016419A3 (en) 2000-07-12
HK1018747A1 (en) 2000-01-07
DK0861093T3 (da) 2000-09-11
EP0861093A1 (en) 1998-09-02
JP3786704B2 (ja) 2006-06-14

Similar Documents

Publication Publication Date Title
BR9510664A (pt) Localização não invasiva de um conjugado de emissão de luz em um animal
DK0841949T3 (da) Anvendelse af saccharid-konjugater
ES2162942T3 (es) Nuevos derivados de acidos carboxilicos, su obtencion y empleo.
MX9101999A (es) Agentes complejantes e inmunoreactivos radioactivos de objetivo, utiles en composiciones y metodos de formacion de imagen terapeuticos y de diagnostico.
EA200100097A1 (ru) Составы для борьбы с человеческими вшами
NO20034312L (no) Terapeutiske midler mot inflammatoriske tarmsykdommer
PT1139739E (pt) Formulacoes agroquimicas
DK0510356T3 (da) Polyethylenglycolproteinkonjugater
ATE449847T1 (de) Hepatitis c rezeptorprotein cd81
ES2164765T3 (es) Heterociclilbenzonitrilos.
NO992902D0 (no) Diagnostiske mark°rer for humane sykdommer
EP1820517A3 (en) Non-invasive localization of a light-emitting conjugate in a mammal
DE59905285D1 (de) Selbstfahrende landwirtschaftliche Erntemaschine
ITPD950099V0 (it) Attrezzatura per la raccolta delle deiezioni prodotte da animali dome-stici tipo cani, gatti o simili
TR200302352U (tr) Otomatik ot toplama ekipmanı.
DE69705772D1 (de) Adamantyl substituierte Oxindole als pharmazeutische Wirkstoffe
KR970056571U (ko) 남성용 구두의 개량뒷굽
PT9170T (pt) Topo de delineador de estradas, de duas pecas acoplaveis
KR970015779U (ko) 트랙터의 벼직파기용 배토장치
KR970050525U (ko) 트랙터용 쟁기
KR970048762U (ko) 남성용 건강 사각팬티
KR970053050U (ko) 트랙터용 다련쟁기
ITMI940718A1 (it) Paletta ecologica sigillata per la raccolta di escrementi di animali.
ITTV960026V0 (it) Paletta monouso particolarmente per la raccolta degli escrementi prodotti da animali domestici.
FI991094A0 (fi) Vetolaite maatalouskoneeseen

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
EG Technical examination (opinion): publication of technical examination (opinion)
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]